Veradermics, Inc — Director's Dealing 2026

Feb 6, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Veradermics, Inc (MANE)
CIK: 0001827635
Period of Report: 2026-02-03

Reporting Person: CHILDS JOHN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-05	Common Stock	C	480269	—	Acquired	480269	Indirect
2026-02-05	Common Stock	C	906862	—	Acquired	1387131	Indirect
2026-02-05	Common Stock	C	520758	—	Acquired	1907889	Indirect
2026-02-05	Common Stock	P	294117	$17	Acquired	2202006	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-05	Series A Convertible Preferred Stock	$	C	480269	Disposed		Common Stock (480269)	Indirect
2026-02-05	Series B Convertible Preferred Stock	$	C	906862	Disposed		Common Stock (906862)	Indirect
2026-02-05	Series C Convertible Preferred Stock	$	C	520758	Disposed		Common Stock (520758)	Indirect
2026-02-03	Stock Option (Right to Buy)	$17	A	51525	Acquired	2036-02-03	Common Stock (51525)	Direct

Footnotes

F1: On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F2: Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.

F3: On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F4: On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F5: This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.